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Rationale

Results

• Silver nanoparticles (AgNPs) exhibit unique
properties due to their size and are becoming
increasingly prevalent in consumer and industrial
1
settings
• AgNPs are known to induce cytotoxicity within in
2
vitro and in vivo environments
• Correlations have been found between bioresponses
3
and concentration of internalized NPs
• The goal was to develop pharmacokinetic profiles for
experimental AgNPs within a lung (A549) cell model

Table 1: AgNP Characterization

Figure 3: TEM images of (A)
citrate and (B) PVP AgNPs

Citrate
PVP

Primary Size (nm) Agglomerate Size (nm) Zeta Potential (mV)
Water
Media
Water
Media
9.3 ± 1.8
22.9 ± 2.3 47.0 ± 2.9 -38.6 ± 1.4 -9.4 ± 0.7
10.6 ± 1.6
19.1 ± 1.5 35.3 ± 1.8 -22.1 ± 1.1 -10.2 ± 0.6
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Figure 4: Toxicity analysis
determined AgNP dosage
for deposition experiments.

Methodology
• Cell Model: Human alveolar cells (A549)
• 10 nm AgNPs: citrate and PVP coatings
• Cytotoxicity: Exposed A549s to AgNPs and analyzed
viability using MTS assay
• Pharmacokinetics: Exposure of A549s to AgNPs and
quantified delivered dose via absorbance analysis
Administered
dose

AgNPs interact with the A549 cells to a
high degree within a static environment.

Figure 1: Explanation
of pharmacokinetic
analysis of AgNPs
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Figure 5: Calibration curves correlated AgNP dose
to peak absorbance
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Figure 2: Images of
A549 cells via (A)
light and (B)
fluorescence
microscopy

Figure 6: AgNP deposition over a range of time
exposures from 2-24 hours

Conclusions
•Using the toxicity analysis, an AgNP dosage of 25 µg/mL was selected.
•A high degree of A549-AgNP association was determined for both experimental particle
sets, with citrate coated AgNPs having a higher degree of interaction than PVP coated AgNPs.
•Future work will repeat these analyses at different nanoparticle sizes and under dynamic
exposure conditions.
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